Latest news
Study Explores PDLIM2 as Prognostic Biomarker and Treatment Target in Lung Adenocarcinoma - Bioengineer.orgBioengineer.org · Sat, 08 Aug 2026 23:29:41 GMTCholangiocarcinoma Market - Future Market InsightsFuture Market Insights · Sat, 08 Aug 2026 13:55:46 GMTNewer cancer therapies improve outcomes in cancer-related CAD - Cold Agglutinin Disease NewsCold Agglutinin Disease News · Sat, 08 Aug 2026 06:36:22 GMTBlossomHill Therapeutics, Clinical-Stage Oncology Drug Developer, Files for Nasdaq Global Select Market IPO - TradingViewTradingView · Fri, 07 Aug 2026 20:09:00 GMTCutaneous Toxicities of Cancer Therapy in Hispanic and Latino Adults - MedscapeMedscape · Fri, 07 Aug 2026 19:15:16 GMTDrug-Induced Autoimmune Inflammatory Myositis in a Patient with Psoriatic Arthritis Receiving Biologic Therapy: A Case Report - EMJEMJ · Fri, 07 Aug 2026 15:22:52 GMTBCMA Targeted Therapies Market - Future Market InsightsFuture Market Insights · Fri, 07 Aug 2026 07:15:41 GMTRadiopharmaceutical May Benefit Patients with Metastatic Prostate Cancer Sooner - WCM NewsroomWCM Newsroom · Thu, 06 Aug 2026 22:47:14 GMT